HEMAMI ApS: Financial statements 2023
CVR: 36402342
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
HEMAMI ApS (CVR 36402342) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK -54,317 compared with DKK -34,422 the year before. Equity in the 2023 report amounted to DKK 86,713. The solvency ratio was 11.8%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -54,317
- Equity
- DKK 86,713
- Total Assets
- DKK 735,823
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | 0 | -54 t. | 87 t. | - |
| 2022 | 0 | -10 t. | -34 t. | 87 t. | - |
| 2021 | - | -9 t. | -85 t. | 87 t. | - |
| 2020 | - | -28 t. | -23 t. | 172 t. | 1 |
| 2019 | 36 t. | 3 t. | 2 t. | 194 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
HEMAMI ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -34,422.
About HEMAMI ApS
HEMAMI ApS is a Danish company of the type Anpartsselskab based in Rødby, founded in 2014. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Hendrik Marinus van Ark. The company is owned by Mikael Gert van Ark and Hendrik Marinus van Ark. The company has 1 employee (2015). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -44,000 compared with DKK -67,476 the year before. Equity in the 2025 report amounted to DKK 88,500.